Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Conditioned media from human amniotic fluid-derived stem cells helps skin heal and protects against aging from sun exposure.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

EMS and EF both show similar skin and fascia changes, but EMS has more severe symptoms and nerve inflammation.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Immune cells are crucial for hair growth and preventing hair loss.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Chicken feather gene mutation helps understand human hair disorders.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Special fiber materials boost the healing properties of certain stem cells.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Somatostatin may help protect hair follicles from immune attacks.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.